潜龙
Lv8
6405 积分
2021-06-29 加入
-
The feasibility of targeted axillary dissection for breast cancer axillary surgery de-escalation after neoadjuvant therapy: A prospective cohort study
6天前
已完结
-
Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding ‘Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3’ by M. P. Goetz et al
1个月前
已完结
-
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment
2个月前
已完结
-
Genomic alterations affecting tumor-infiltrating lymphocytes and PD-L1 expression patterns in triple-negative breast cancer
2个月前
已完结
-
Evaluation of large language models in breast cancer clinical scenarios: A comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2
2个月前
已完结
-
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2个月前
已完结
-
Evaluation of large language models in breast cancer clinical scenarios: A comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2
2个月前
已完结
-
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
2个月前
已完结
-
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
2个月前
已完结
-
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
2个月前
已完结